PPSu-PEG copolymers and their application in the preparation of cisplatin-loaded nanoparticles

Current Nanoscience

Volumn 7, Issue 4, 2011, Pages 503-509

  Kyriakopoulou, Spiridoula ^a   Mattheolabakis, George ^a   Papadimitriou, Sofia ^b   Karavas, Evangelos ^c   Bikiaris, Dimitrios ^b   Avgoustakis, Konstantinos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Pharmaceutical Industry   (Greece)

Author keywords

Cisplatin; Cytotoxicity; Hyperthermia; Nanoparticles; Poly(propylene succinate) poly(ethyleneglycol)

Indexed keywords

ANTICANCER ACTIVITIES; AQUEOUS MEDIA; AVERAGE SIZE; CIS-PLATIN; COLLOIDAL STABILITY; DOUBLE EMULSIONS; DRUG RELEASE PROPERTIES; HIGH SALT CONCENTRATION; HT 29 CELLS; HYPERTHERMIA; IN-VITRO; INCUBATION TEMPERATURES; NANOCARRIERS; ONE POT; POLY(PROPYLENE SUCCINATE); POTENTIAL VALUES; TEMPERATURE-SENSITIVE;

COPOLYMERIZATION; COPOLYMERS; EMULSIFICATION; NANOPARTICLES; PLASTIC PRODUCTS; PLATINUM COMPOUNDS; POLYETHYLENE OXIDES; PROPYLENE; THERMODYNAMIC PROPERTIES;

POLYETHYLENE GLYCOLS;

CISPLATIN; NANOPARTICLE; POLY(PROPYLENE SUCCINATE) POLY(ETHYLENEGLYCOL); UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONCENTRATION RESPONSE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; EMULSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TEMPERATURE; POLYMERIZATION; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

EID: 79960002414     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341311796196880     Document Type: Article

References (22)

1. Ponzani, V.; Bressolle, F.; Haug, I.J.; Galtier, M.; Blayac, J.P. Cisplatininduced renal toxicity and toxicity-modulating strategies: review. Cancer Chemother. Pharmacol., 1994, 35, 1-9.
2. Schrump, D.S.; Nguyen, D.M. Novel molecular targeted therapy for esophageal cancer. J. Surg. Oncol., 2005, 92, 257-261.
3. Nobuto, H.; Sugita, T.; Kubo, T.; Shimose, S.; Yasunaga, Y.; Murakami, T.; Ochi, M. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int. J. Cancer, 2004, 109, 627-635.
4. Kim, G.; Nie, S. Targeted Cancer nanotherapy. Mater. Today, 2005, 8, 28-33.
5. Yang, M.; Ding, Y.T.; Zhang, L.Y.; Qian, X.P.; Jiang, X.Q.; Liu, B.R. Novel thermosensitive polymeric micelles for docetaxel delivery. J. Biomed. Mater. Res. A, 2007, 81, 847-857.
6. Reisen, J.L.B.; Polley, G.T.; Verheijen, P.J.T. Structural targeting for heat integration retrofit. Appl. Therm. Eng., 1998, 18, 283-294.
7. Kong, G.; Dewhirst, M.W. Hyperthermia and liposomes. Int. J. Hyperther., 1999, 15, 345-370.
8. Chilkoti, A.; Dreher, M.R.; Meyer, D.E.; Raucher, D. Targeted drug delivery by thermally responsive polymers. Adv. Drug Deliv. Rev., 2002, 54, 613-630.
9. Meyer, D.E.; Shin, B.C.; Kong, G.A.; Dewhirst, M.W.; Chilkoti, A. Drug targeting using thermally responsive polymers and local hyperthermia. J. Control. Release, 2001, 74, 213-224.
10. Riehemann, K.; Schmitt, O.; Ehlers, E.M. The effects of thermochemotherapy using cyclophosphamide plus hyperthermia on the malignant pleural mesothelioma in vivo. Ann. Anat., 2005, 187, 215-213.
11. Bikiaris, D.N.; Papageorgiou, G.Z.; Papadimitriou, S.A.; Karavas, E.; Avgoustakis, K. Novel biodegradable polyester poly(propylene succinate): Synthesis and application in the preparation of solid dispersions and nanoparticles of a water-soluble drug. AAPS PharmSciTech, 2009, 10, 138-146
12. Bikiaris, D.; Karavelidis, V.; Karavas, E. Effectiveness of various drug carriers in controlled release formulations of raloxifene HCl prepared by melt mixing. Curr. Drug Deliv., 2009, 6, 425-436.
13. Bikiaris, D.N.; Papageorgiou, G.Z.; Achilias, D.S. Synthesis and comparative biodegradability studies of three poly(alkylene succinate)s. Polym. Degrad. Stabil., 2006, 91, 31-43.
14. Avgoustakis, K. Pegylated Poly(Lactide) and Poly(lactide-co-glycolide) Nanoparticles: Preparation, properties and possible applications in drug delivery. Curr. Drug Deliv., 2004, 1, 321-333.
15. Bikiaris, D.N.; Achilias, D.S. Synthesis of poly(alkylene succinate) biodegradable polyesters I. Mathematical modelling of the esterification reaction. Polymer, 2006, 47, 4851-4860.
16. Mattheolabakis, G.; Panagi, Z.; Taoufik, E.; Roberts, M.; Avgoustakis, K. In vivo investigation of toxicity and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles. E.J. Pharm. Biopharm., 2009, 71, 190-195.
17. Avgoustakis, K.; Beletsi, A.; Panagi, Z.; Klepetsanis, P.; Karydas, A.G.; Ithakissios, D.S. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release, 2002, 79, 123-135.
18. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assay. J. Immunol. Methods, 1983, 65, 55-63.
19. Riley, T.; Govender, T.; Stolnik, S.; Xiong, C.D.; Garnett, M.C.; Illum, L.; Davis S.S. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. Colloids Surf. B: Biointerfaces, 1999, 16, 147-159.
20. Maeda, H.; Bharate, G.Y.; Daruwalla, J. Polymeric drugs for efficient tumortargeted drug delivery based on EPR-effect. E.J. Pharm. Biopharm., 2009, 71, 409-419.
21. Alexis, F.; Pridgen, E.; Molnar, L.K.; Farokhzad, O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm., 2008, 5, 505-515.
22. Beletsi, A.; Klepetsanis, P.; Ithakissios, D.S.; Kounias, S.; Stavropoulos, A.; Avgoustakis, K. Simultaneous optimization of cisplatin-loaded PLGA-mPEG nanoparticles with regard to their size and drug encapsulation. Curr. Nanosci., 2008, 4, 173-178.